VIGOR++
Virtual GastrOintestinal tRact
| Coordinatore | TECHNISCHE UNIVERSITEIT DELFT
Organization address
address: Mekelweg 2 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 3˙925˙530 € |
| EC contributo | 2˙990˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2009-6 |
| Funding Scheme | CP |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-02-01 - 2014-05-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
TECHNISCHE UNIVERSITEIT DELFT
Organization address
address: Mekelweg 2 contact info |
NL (Delft) | coordinator | 0.00 |
| 2 |
Nome Ente NON disponibile
Organization address
city: BERLIN contact info |
DE (BERLIN) | participant | 0.00 |
| 3 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 0.00 |
| 4 |
BIOTRONICS 3D LIMITED
Organization address
address: PARK PLACE 1 contact info |
UK (LONDON) | participant | 0.00 |
| 5 |
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse 101 contact info |
CH (ZUERICH) | participant | 0.00 |
| 6 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 0.00 |
| 7 |
VODERA LIMITED
Organization address
address: APPLETON COURT 1 CALDER PARK contact info |
UK (WAKEFIELD) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Inflammatory Bowel diseases (IBDs) constitute on of the largest healthcare problems in the Western World, affecting over 1 million European citizens alone, 700,000 of whom suffer from Crohn's disease.nGrading of Crohn's disease severity is important to determine treatment strategy and to quantify the response to treatment. Colonoscopy in combination with the assessment of biopsy samples is considered the reference standard for diagnosis of all IBD. However, the procedure is invasive and requires extensive bowel preparation, which is considered very burdensome by most patients. Moreover, it only gives information on superficial abnormalities.nThe VIGOR\ project aims to create a multiscale, personalised GI tract model, which facilitates improved detection of Crohn's disease and drives an accurate index of Crohn's disease severity.nVIGOR\ will acquire laboratory, MRI, colonoscopy and microscopy (histopathology) data in order to develop the targeted ICT tools. A novel integration of existing models is employed to predict features on the molecular to cellular scale (microscopy/colonoscopy) from descriptive properties at the organ to patient scales (MRI/laboratory). Effectively, this would render the standard methods (colonoscopy/biopsy) superfluous.nThe tools sustain early diagnosis, improved therapy planning and a better quality of life for patients. The clinical benefit is demonstrated by an assessment of the tools' performance to predict Crohn's disease status. Moreover, a preliminary study will be performed in which the effect of therapy is evaluated using the VIGOR\ tools.nThe consortium harbours leading groups in abdominal radiology, medical image analysis, modelling, scientific visualization, gastroenterology and commercial diffusion. Importantly, it has solid plans for the commercialisation of the generated innovations. Notably, the ICT tools are developed in a clinically used environment, 3Dnet™ Suite, so that they can be readily commercialized.